Renal Cell Carcinoma
Conference Coverage
Germline testing in advanced cancer can lead to targeted treatment
In a study of nearly 12,000 cancer patients, 7%-9% of patients had targetable germline alterations.
News
Oncologists’ income and satisfaction are up
Conference Coverage
Video coaching may relieve anxiety and distress for long-distance cancer caregivers
Conference Coverage
ASCO goes ahead online, as conference center is used as hospital
From the Journals
Excess cancer deaths predicted as care is disrupted by COVID-19
Feature
ASCO panel outlines cancer care challenges during COVID-19 pandemic
Feature
Will coronavirus restrictions lead to more advanced cancers?
From the Journals
European cancer centers restructure care in the era of COVID-19
From the Journals
Want to keep cancer patients and providers safe during the pandemic? Here’s how
Prescreening, telemedicine, and limited interventions top the list of best practices for patients, while PPE, telecommuting, and wellness/stress...
Feature
Cancer patients report delays in treatment because of COVID-19
Half of survey respondents in active treatment reported changes, delays, or disruptions to care.
From the Journals
Cancer care ‘transformed in space of a month’ because of pandemic
Changes brought about by COVID-19 may endure after the pandemic is over.